Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Church & Dwight Company (NY: CHD )

104.75 +4.84 (+4.84%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Church & Dwight Company

< Previous 1 2 3 4 5 6 7 8 9 Next >
Should Proctor and Gamble be a Staple in Your Portfolio?
The world’s largest consumer goods maker Proctor & Gamble (NYSE: PG) stock has fallen (-21%) for the year. Shares hit pandemic highs of $146.92 in November 
Via MarketBeat
Exposures COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2022
Upgrades 
Via Benzinga
Where Church & Dwight Co Stands With Analysts
Within the last quarter, Church & Dwight Co (NYSE:CHD) has observed the following analyst ratings: 
Via Benzinga
Expert Ratings for Church & Dwight Co
Within the last quarter, Church & Dwight Co (NYSE:CHD) has observed the following analyst ratings: 
Via Benzinga
Church & Dwight Acquires Acne Treatment Products Maker Hero For $630M
Via Benzinga
Clorox Pandemic Gains Have Been Bleached, Time to Get Back In?
Consumer cleaning products maker Clorox (NYSE: CLX) stock skyrocketed during the pandemic from unprecedented demand for its cleaning supplies but 
Via MarketBeat
Topics Economy
Exposures COVID-19 Interest Rates Supply Chain
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2022
Upgrades 
Via Benzinga
Coca-Cola Price Target Cut By This Analyst? Plus Rocket Pharmaceuticals Likely To Rally Around 306%
Wells Fargo cut the price target on The Coca-Cola Company (NYSE: KO) from $72 to $66. Wells Fargo analyst Chris Carey maintained an Overweight rating on the stock. Coca-Cola shares rose 0.3% to $56.20... 
Via Benzinga
Church & Dwight Stock Falls On Q2 Top-Line Miss, Dismal Outlook
Via Benzinga
Church & Dwight to Webcast Discussion of Third Quarter 2022 Results on October 28
From Church & Dwight Co., Inc.
Via Business Wire
Does the Post-Pandemic Company Clorox Company Offer Opportunity?
The Clorox Company (NYSE: CLX) sailed to higher and higher stock prices during the heights of the pandemic and shortly after, as consumers whisked cleaning products off the shelves in droves. The... 
Via MarketBeat
Exposures COVID-19
U.S. Dollar Rally
Good Morning Everyone! Good Morning Everyone! Remember, the most important meme stock on the planet reports today. Here's what analysts are saying about GameStop:   SELL: 3 Wall Street Banks HOLD: 1... 
Via Benzinga
Church & Dwight to Acquire Hero, creator of the Mighty Patch® Brand for $630 million
From Church & Dwight Co., Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2022
  
Via Benzinga
Church & Dwight Webcasts Presentation at the 2022 Barclays Global Consumer Staples Conference
From Church & Dwight Co., Inc.
Via Business Wire
Is Church & Dwight Co. Inc. (NYSE: CHD) a Buy for Dividend Investors?
Church & Dwight (NYSE: CHD) might not exactly be a household name, but you've likely heard of many of the company's brands: ARM & HAMMER, Trojan, First Response, Nair, Spinbrush, OxiClean, Orajel,... 
Via MarketBeat
Short Volatility Alert: Church & Dwight Co., Inc.
On Tuesday, shares of Church & Dwight Co., Inc. (NYSE: CHD) experienced volatile short activity. After the activity, the stock price went down -1.74% to $87.06. The overall sentiment for CHD has been... 
Via Benzinga
Apple To $177? Here Are 5 Other Price Target Changes For Tuesday
Keybanc raised the price target on Apple Inc. (NASDAQ: AAPL) from $173 to $177. However, Keybanc analyst Brandon Nispel maintained the stock with an Overweight. Apple shares fell 0.8% to $160.16 in... 
Via Benzinga
The Colgate-Palmolive Growth Outlook Brightens
Colgate-Palmolive is a fairly-valued stock in relation to its peers and one that pays a nice 2.4% yield while coming with an outlook for improving margin. 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Church & Dwight Co: Q2 Earnings Insights
  Church & Dwight Co (NYSE:CHD) reported its Q2 earnings results on Friday, July 29, 2022 at 06:55 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Church & Dwight Reports Q2 2022 Results
From Church & Dwight Co., Inc.
Via Business Wire
Earnings Scheduled For July 29, 2022
Companies Reporting Before The Bell • Capital Product Partners (NASDAQ:CPLP) is expected to report quarterly earnings at $1.13 per share on revenue of $72.73 million. 
Via Benzinga
Is Procter & Gamble One of the Best Dividend Stocks of All Time?
The Procter & Gamble Company (NYSE: PG) might be an investor's dream. The company propagates some household names and brands, such as Pampers, Bounce, Dreft, Gain, Tide, Bounty, Braun, Gillette, Old... 
Via MarketBeat
Church & Dwight Co., Inc. Declares 486th Regular Quarterly Dividend
From Church & Dwight Co., Inc.
Via Business Wire
5 Analysts Have This to Say About Church & Dwight Co
Over the past 3 months, 5 analysts have published their opinion on Church & Dwight Co (NYSE:CHD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Church & Dwight Stock Key Rating Jumps With Earnings Due
Church & Dwight's stock's relative strength line, which compares a stock vs. the S&P 500, is at the highest point since late 2020. 
Via Investor's Business Daily
Church & Dwight to Webcast Discussion of Second Quarter 2022 Results on July 29
From Church & Dwight Co.
Via Business Wire
Evofem Biosciences (EVFM) Stock Remains in Spotlight With Contraception Access Deal
Evofem Biosciences has already announced a strategic partnership. Here's why this new deal is great news for EVFM stock. 
Via InvestorPlace
Morgan Stanley To $80? Here's The Biggest Price Target Changes For Tuesday
Keybanc cut AvalonBay Communities, Inc. (NYSE: AVB) price target from $275 to $237. AvalonBay Communities shares rose 1.9% to close at $198.77 on Monday. 
Via Benzinga
EVFM Stock: Contraception Maker Evofem Biosciences Doubles After Roe Decision
Evofem Biosciences is in the spotlight following the overturning of Roe v. Wade. Here's why EVFM stock is a name to watch. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.